Rinat Sergeev Drug-Resistant Tuberculosis Modeling the Dynamic Relationship Between HIV and the Risk of
暂无分享,去创建一个
T. Cohen | M. Murray | C. Colijn | R. Sergeev | M. Murray
[1] S. Rüsch-Gerdes,et al. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010 , 2012, Emerging infectious diseases.
[2] P. V. van Helden,et al. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. , 2011, American journal of respiratory and critical care medicine.
[3] T. Cohen,et al. Models to understand the population-level impact of mixed strain M. tuberculosis infections. , 2011, Journal of theoretical biology.
[4] S. Borrell,et al. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[5] Ellen Brooks-Pollock,et al. Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. , 2011, The Journal of infectious diseases.
[6] R. Chaisson,et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[7] L. Ramakrishnan,et al. Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism , 2011, Cell.
[8] Reuben Granich,et al. HIV infection-associated tuberculosis: the epidemiology and the response. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Woojun Park,et al. Trade-off between antibiotic resistance and biological fitness in Acinetobacter sp. strain DR1. , 2010, Environmental microbiology.
[10] Sebastian Bonhoeffer,et al. Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations , 2010, Antimicrobial Agents and Chemotherapy.
[11] D. van Soolingen,et al. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. , 2010, The Lancet. Infectious diseases.
[12] S. Borrell,et al. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] C. Dye,et al. Slow Elimination of Multidrug-Resistant Tuberculosis , 2009, Science Translational Medicine.
[14] Andrew R. Francis,et al. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.
[15] S. Lawn,et al. Epidemiology of HIV-associated tuberculosis , 2009, Current opinion in HIV and AIDS.
[16] Emily S. Brouwer,et al. Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review , 2009, PloS one.
[17] Simon Bergqvist,et al. Zur Frage der tuberkulsen Primrinfektion bei jungen Erwachsenen , 2009 .
[18] L. Tanoue. Facing Extensively Drug-Resistant Tuberculosis — A Hope and a Challenge , 2009 .
[19] S. Gagneux. Fitness cost of drug resistance in Mycobacterium tuberculosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] T. Cohen,et al. Latent Coinfection and the Maintenance of Strain Diversity , 2009, Bulletin of mathematical biology.
[21] Richard D Moore,et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil , 2008, AIDS.
[22] S. Swindells,et al. Extensively drug-resistant tuberculosis. , 2008, The American journal of medicine.
[23] P. Sonnenberg,et al. Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines , 2008, AIDS.
[24] R. Chaisson,et al. Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing , 2008, Proceedings of the National Academy of Sciences.
[25] M. Pai,et al. Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis , 2008, Annals of Internal Medicine.
[26] A. Galvani,et al. The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach , 2008, Epidemiology and Infection.
[27] R. Frothingham,et al. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population. , 2008, The Journal of infectious diseases.
[28] J. Lazarus,et al. Tuberculosis–HIV co‐infection: policy and epidemiology in 25 countries in the WHO European region , 2008, HIV medicine.
[29] P. Nunn,et al. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[30] P. V. van Helden,et al. Spread of a Low-Fitness Drug-Resistant Mycobacterium tuberculosis Strain in a Setting of High Human Immunodeficiency Virus Prevalence , 2008, Journal of Clinical Microbiology.
[31] Baojun Song,et al. Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment. , 2008, Mathematical biosciences and engineering : MBE.
[32] Christopher Dye,et al. Eliminating human tuberculosis in the twenty-first century , 2008, Journal of The Royal Society Interface.
[33] K. Weyer,et al. Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[34] S. Basu,et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study , 2007, The Lancet.
[35] K. Laserson,et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[36] T. Holtz,et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. , 2007, The Journal of infectious diseases.
[37] G. Rutherford,et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda , 2007, AIDS.
[38] R. Hayes,et al. Epidemiology of Tuberculosis in a High HIV Prevalence Population Provided with Enhanced Diagnosis of Symptomatic Disease , 2007, PLoS medicine.
[39] L. Myer,et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. , 2007, American journal of respiratory and critical care medicine.
[40] J. Manson,et al. Prospective Study of , 2007 .
[41] A. R. Escombe,et al. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. , 2006, The American journal of tropical medicine and hygiene.
[42] C. Dye,et al. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. , 2006, The Journal of infectious diseases.
[43] K. Freedberg,et al. CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa: Implications for Prophylaxis and Treatment , 2006, Journal of acquired immune deficiency syndromes.
[44] C. D. Long,et al. The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis , 2006, Science.
[45] L. Myer,et al. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] R. Atun,et al. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model , 2005, International journal of STD & AIDS.
[47] M. Feldman,et al. EVOLUTION OF ANTIBIOTIC RESISTANCE BY HUMAN AND BACTERIAL NICHE CONSTRUCTION , 2005 .
[48] D. Caugant,et al. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. , 2004, FEMS immunology and medical microbiology.
[49] Ted Cohen,et al. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness , 2004, Nature Medicine.
[50] T. Chou,et al. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance , 2004, Nature Medicine.
[51] R. Hayes,et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. , 2004, American journal of respiratory and critical care medicine.
[52] Christopher Dye,et al. Tuberculosis epidemics driven by HIV: is prevention better than cure? , 2003, AIDS.
[53] V. Leimane,et al. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[54] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[55] Maja Krčum,et al. System dynamics simulation modelling of propulsion system (BSVPAM) , 2003 .
[56] Ted Cohen,et al. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. , 2003, The Lancet. Infectious diseases.
[57] Brian G. Williams,et al. Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis , 2002, Science.
[58] S. Gillespie,et al. Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. , 2002, Microbial drug resistance.
[59] J. Sacarlal,et al. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[60] C. Dye,et al. Will tuberculosis become resistant to all antibiotics? , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[61] M G Reynolds,et al. Compensatory evolution in rifampin-resistant Escherichia coli. , 2000, Genetics.
[62] P. Sonnenberg,et al. Tuberculosis treatment failure and drug resistance--same strain or reinfection? , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[63] A. Reingold,et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. , 2000, Lancet.
[64] P. Sonnenberg,et al. Drug-resistant pulmonary tuberculosis in a cohort of southern African goldminers with a high prevalence of HIV infection. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[65] G. Ippolito,et al. Negative Predictors of Survival in HIV-Infected Patients with Culture-Confirmed Pulmonary Tuberculosis , 1999, Infection.
[66] J. Glynn. Resurgence of tuberculosis and the impact of HIV infection. , 1998, British medical bulletin.
[67] J. Blázquez,et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection , 1997, The Lancet.
[68] P E Fine,et al. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection , 1997, Epidemiology and Infection.
[69] R. Wood,et al. HIV infection is not associated with an increased rate of drug-resistant tuberculosis. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[70] S. A. Abdool Karim,et al. A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[71] F. Plummer,et al. Recent transmission of tuberculosis in a cohort of HIV‐1‐infected female sex workers in Nairobi, Kenya , 1997, AIDS.
[72] R. Nogami,et al. A Five Year Epidemiological Study of Systemic Scleroderma(SSc) in Kumamoto Prefecture from 1988 to 1993. , 1997 .
[73] T. Frieden,et al. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. , 1996, JAMA.
[74] J. Witte,et al. Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. , 1996, American journal of epidemiology.
[75] R. O'brien,et al. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993 , 1996, AIDS.
[76] P. Piot,et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. , 1995, The New England journal of medicine.
[77] Hadi Dowlatabadi,et al. Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .
[78] A. Kamali,et al. Two-year HIV-1-associated mortality in a Ugandan rural population , 1994, The Lancet.
[79] K. McAdam,et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[80] R. Hayes,et al. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. , 1993, AIDS.
[81] K. Kerlikowske,et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. , 1992, The American review of respiratory disease.
[82] K. D. de Cock,et al. HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire , 1992, AIDS (London).
[83] K. McAdam,et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. , 1992, The American review of respiratory disease.
[84] G. Schoolnik,et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.
[85] M. Lafontaine,et al. Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. , 1991, BMJ.
[86] K. Stýblo. The impact of HIV infection on the global epidemiology of tuberculosis. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.
[87] R. Chaisson,et al. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[88] R. Luzzati,et al. NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.
[89] T. Quinn,et al. HIV infection in patients with tuberculosis in Kinshasa, Zaire. , 1989, The American review of respiratory disease.
[90] B. Wallace. Can "Stepping Stones" Form Stairways? , 1989, The American Naturalist.
[91] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[92] S. Radhakrishna,et al. The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. , 1982, Tubercle.
[93] G W Comstock,et al. The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.
[94] S. Grzybowski,et al. [The current risk of contracting evolutive tuberculosis, in Saskatchewan, according to the state of previous tuberculin tests and x-ray image]. , 1971, Bulletin of the International Union against Tuberculosis.
[95] V. Springett. Ten-year results during the introduction of chemotherapy for tuberculosis. , 1971, Tubercle.
[96] J. Myers. The natural history of tuberculosis in the human body; forty-five years of observation. , 1965, JAMA.
[97] G. Várela. Comparison of Bacteriological Results with Fresh Faeces and Dried Faeces on Filter Paper in Cases of Diarrhoea. , 1955 .
[98] C. Lowe. Recent Trends in Survival of Patients with Respiratory Tuberculosis , 1954, British journal of preventive & social medicine.
[99] W. Tattersall. The survival of sputum-positive consumptives; a study of 1,192 cases in a county borough between 1914 and 1940. , 1947, Tubercle.
[100] B. Thompson. Survival Rates in Pulmonary Tuberculosis , 1943, British medical journal.
[101] T. Madsen,et al. Studies on the epidemiology of tuberculosis in Denmark. , 1942 .
[102] H. Hilleboe. Post-Sanatorium Tuberculosis Survival Rates in Minnesota. , 1941 .
[103] G. J. Drolet,et al. Present Trend of Case Fatality Rates in Tuberculosis. , 1938 .